BRANDY HAYES: Open Payments
NPI 1285091892 · MESA, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$796 in 40 payments from 12 companies in 2025. Trend: 2023 $176 · 2024 $449 · 2025 $796
Food & beverage: $796
| Company | Payments | Amount |
|---|---|---|
| Novartis Pharmaceuticals Corporation | 12 | $254 |
| Kestra Medical Technology Services, Inc. | 7 | $142 |
| Merck Sharp & Dohme LLC | 4 | $74 |
| Amgen Inc. | 5 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Actelion Pharmaceuticals US, Inc. | 2 | $47 |
| Medtronic, Inc. | 1 | $42 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $32 |
| AltaThera Pharmaceuticals LLC | 1 | $22 |
| Alnylam Pharmaceuticals Inc. | 1 | $19 |
Products named: LEQVIO, Assure WCD, REPATHA, JARDIANCE, OPSUMIT, COREVALVE EVOLUT R, CAPVAXIVE, VERQUVO.
Industry payments across AZ — which companies pay providers there.
